金域医学 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	7.2B	8.5B	15.5B	11.9B	8.2B
Revenue Growth %	-15.8%	-44.8%	29.6%	44.9%	--
Total Revenue	7.2B	8.5B	15.5B	11.9B	8.2B
Cost Of Revenue	4.8B	5.4B	8.8B	6.3B	4.4B
+Gross Profit	2.4B	3.1B	6.7B	5.6B	3.8B
Gross Margin %	33.1%	36.5%	43.1%	47.3%	46.7%
Total Operating Cost	7.4B	8.1B	12.2B	9.2B	6.5B
Selling Expenses	931.0M	1.0B	1.5B	1.4B	990.0M
Admin Expenses	598.0M	715.0M	996.0M	888.0M	623.0M
Rd Expenses	400.0M	467.0M	633.0M	518.0M	397.0M
Finance Expenses	-2.8M	-1.1M	-12.6M	10.1M	17.6M
+Operating Income	-273.0M	760.0M	3.3B	2.8B	1.8B
Operating Margin %	-3.8%	8.9%	21.6%	23.3%	22.0%
Non Operating Income	4.6M	3.8M	2.1M	2.0M	2.2M
Non Operating Expenses	170.0M	23.3M	28.6M	31.2M	8.6M
Investment Income	-37.1M	263.0M	-10.8M	-7.3M	-18.7M
Fair Value Change Income	-30.8M	--	--	--	--
Asset Disposal Income	6.4M	2.2M	4.0M	-9.7M	2.1M
Asset Impairment Loss	72.6M	-519,000	-232,200	519,000	879,000
Other Income	39.6M	78.2M	76.1M	79.7M	66.1M
Income Before Tax	-439.0M	740.0M	3.3B	2.7B	1.8B
Income Tax	-23.9M	103.0M	476.0M	384.0M	237.0M
+Net Income	-415.0M	637.0M	2.8B	2.4B	1.6B
Net Margin %	-5.8%	7.5%	18.4%	19.8%	19.1%
Net Income Attributable	-381.0M	643.0M	2.8B	2.2B	1.5B
Minority Interest	-33.5M	-6.5M	90.2M	144.0M	63.7M
Eps Basic	-0.82	1.38	5.91	4.80	3.29
Eps Diluted	-0.82	1.38	5.90	4.76	3.27

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	2.4B	2.5B	2.9B	2.7B	1.6B
Accounts Receivable	4.4B	5.3B	7.0B	4.7B	2.7B
Notes Receivable	--	--	--	--	--
Notes And Accounts Receivable	4.4B	5.3B	7.0B	4.7B	2.7B
Prepayments	8.5M	8.8M	11.4M	8.6M	12.7M
Inventory	198.0M	248.0M	405.0M	345.0M	238.0M
Total Current Assets	7.3B	8.3B	10.7B	7.9B	4.8B
Long Term Equity Investment	175.0M	262.0M	205.0M	214.0M	155.0M
Fixed Assets	--	1.7B	1.7B	1.6B	1.2B
Fixed Assets Total	1.3B	1.7B	1.7B	1.6B	1.2B
Construction In Progress	--	359.0M	206.0M	143.0M	17.7M
Construction In Progress Total	528.0M	359.0M	206.0M	143.0M	17.7M
Intangible Assets	168.0M	150.0M	152.0M	68.4M	139.0M
Long Term Deferred Expenses	181.0M	245.0M	255.0M	198.0M	177.0M
Total Non Current Assets	3.1B	3.5B	3.2B	2.8B	1.9B
Total Assets	10.4B	11.8B	13.9B	10.8B	6.6B
Short Term Borrowings	1.0M	1.0M	--	--	37.2M
Accounts Payable	1.7B	2.1B	3.0B	2.3B	1.6B
Advance Receipts	--	--	--	--	--
Contract Liabilities	54.8M	76.8M	105.0M	132.0M	93.1M
Total Current Liabilities	2.2B	2.7B	4.6B	3.7B	2.3B
Long Term Borrowings	515.0M	268.0M	143.0M	249.0M	379.0M
Total Non Current Liabilities	684.0M	531.0M	435.0M	500.0M	451.0M
Total Liabilities	2.9B	3.2B	5.0B	4.2B	2.8B
Paid In Capital	463.0M	469.0M	467.0M	466.0M	459.0M
Capital Reserve	1.2B	1.5B	1.5B	1.4B	924.0M
Surplus Reserve	234.0M	234.0M	234.0M	233.0M	107.0M
Retained Earnings	5.4B	6.2B	6.4B	4.2B	2.3B
Minority Equity	150.0M	185.0M	243.0M	219.0M	89.4M
Equity Attributable	7.3B	8.4B	8.6B	6.3B	3.8B
Total Equity	7.5B	8.5B	8.9B	6.5B	3.9B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	7.6B	9.8B	13.0B	10.0B	7.1B
Tax Refunds Received	722,000	20.2M	2.3M	1.5M	937,100
Total Operating Cash Inflow	7.7B	10.0B	13.2B	10.2B	7.2B
Cash Paid For Goods	3.8B	4.8B	6.1B	4.5B	3.0B
Cash Paid To Employees	1.9B	2.4B	2.8B	2.0B	1.4B
Taxes Paid	183.0M	413.0M	589.0M	296.0M	165.0M
Total Operating Cash Outflow	6.8B	8.8B	11.2B	8.1B	5.6B
Operating Cash Flow	906.0M	1.2B	1.9B	2.1B	1.5B
Total Investing Cash Inflow	16.7M	237.0M	32.5M	76.7M	13.3M
Total Investing Cash Outflow	472.0M	872.0M	881.0M	1.1B	648.0M
Investing Cash Flow	-456.0M	-635.0M	-848.0M	-1.0B	-634.0M
Cash From Borrowings	369.0M	206.0M	80.0M	--	464.0M
Dividends And Interest Paid	428.0M	890.0M	701.0M	214.0M	113.0M
Debt Repayments	98.6M	204.0M	179.0M	81.7M	616.0M
Total Financing Cash Inflow	369.0M	248.0M	128.0M	351.0M	516.0M
Total Financing Cash Outflow	858.0M	1.3B	997.0M	404.0M	730.0M
Financing Cash Flow	-489.0M	-1.1B	-869.0M	-53.0M	-214.0M
Net Change In Cash	-27.1M	-458.0M	270.0M	1.0B	671.0M
Ending Cash Balance	2.4B	2.5B	2.9B	2.6B	1.6B
Capex	446.0M	715.0M	841.0M	952.0M	551.0M